A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.
Clinical trial NCT02601378 · TERMINATED
Trial details
- NCT number
- NCT02601378
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2022-01-07
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.